AEON Biopharma, Inc. Stock Nasdaq
Equities
AEON
US00775E1029
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.725 USD | 0.00% | 0.00% | 0.00% |
Apr. 12 | AEON Biopharma, Inc. announced that it has received $15 million in funding from Daewoong Pharmaceutical Co., Ltd | CI |
Apr. 01 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 161M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 58.81% |
1st Jan change | Capi. | |
---|---|---|
-2.28% | 103B | |
+0.35% | 95.71B | |
+1.69% | 22.02B | |
-16.63% | 20.9B | |
-9.30% | 17.85B | |
-42.83% | 16.21B | |
-14.91% | 15.52B | |
+3.86% | 13.86B | |
+33.93% | 12.04B |
- Stock Market
- Equities
- AEON Stock
- AEON Stock